Table 2.
Variables | Univariable modela | Multivariable modela | ||||
---|---|---|---|---|---|---|
HR | 95% CI of HR | P valueb | HR | 95% CI of HR | P valueb | |
GSE39582 training (N = 278) | ||||||
Seven-lncRNA risk score | 2.71 | 2.087–3.519 | < 0.001 | 2.749 | 2.111–3.579 | < 0.001 |
Age | 0.999 | 0.983–1.014 | 0.877 | 1.01 | 0.993–1.027 | 0.261 |
Gender | 1.457 | 0.951–2.233 | 0.084 | 1.428 | 0.925–2.205 | 0.108 |
TNM stage I | 1.00(referent) | 1.00(referent) | ||||
TNM stage II | 10,245,861 | 0.000- | 0.994 | 5,864,621 | 0.000- | 0.995 |
TNM stage III | 16,355,014 | 0.000- | 0.993 | 7,823,016 | 0.000- | 0.994 |
TNM stage IV | 52,014,059 | 0.000- | 0.993 | 42,817,026 | 0.000- | 0.994 |
GSE39582 validation (N = 274) | ||||||
Seven-lncRNA risk score | 1.978 | 1.558–2.511 | < 0.001 | 1.875 | 1.435–2.449 | < 0.001 |
Age | 1 | 0.984–1.016 | 0.977 | 0.998 | 0.982–1.015 | 0.839 |
Gender | 1.117 | 0.73–1.709 | 0.609 | 1.559 | 0.996–2.442 | 0.052 |
TNM stage I | 1.00(referent) | 1.00(referent) | ||||
TNM stage II | 4.42 | 0.598–32.673 | 0.145 | 3.223 | 0.434–23.944 | 0.253 |
TNM stage III | 10.644 | 1.465–77.354 | 0.02 | 5.997 | 0.808–44.512 | 0.08 |
TNM stage IV | 48.847 | 6.533–365.212 | < 0.001 | 40.881 | 5.415–308.664 | < 0.001 |
Entire GSE39582 (N = 552) | ||||||
Seven-lncRNA risk score | 2.263 | 1.907–2.685 | < 0.001 | 2.248 | 1.879–2.69 | < 0.001 |
Age | 0.999 | 0.988–1.011 | 0.927 | 1.004 | 0.992–1.015 | 0.538 |
Gender | 1.278 | 0.946–1.726 | 0.110 | 1.536 | 1.132–2.084 | 0.006 |
TNM stage I | 1.00(referent) | 1.00(referent) | ||||
TNM stage II | 7.479 | 1.036–53.984 | 0.046 | 4.652 | 0.642–33.689 | 0.128 |
TNM stage III | 14.37 | 1.999–103.274 | 0.008 | 6.9 | 0.95–50.115 | 0.056 |
TNM stage IV | 55.189 | 7.558–402.996 | < 0.001 | 42.134 | 5.746–308.933 | < 0.001 |
GSE17538 validation (N = 200) | ||||||
Seven-lncRNA risk score | 1.945 | 1.317–2.873 | < 0.001 | 1.905 | 1.206–3.008 | 0.0057 |
Age | 0.98 | 0.962–0.999 | 0.043 | 0.989 | 0.968–1.01 | 0.312 |
Gender | 0.75 | 0.441–1.276 | 0.289 | 0.848 | 0.481–1.493 | 0.567 |
TNM stage I | 1.00(referent) | 1.00(referent) | ||||
TNM stage II | 5.177 | 0.668–40.132 | 0.116 | 4.313 | 0.552–33.69 | 0.163 |
TNM stage III | 10.278 | 1.387–76.172 | 0.023 | 8.064 | 1.076–60.457 | 0.0423 |
TNM stage IV | 49.435 | 6.615–369.41 | < 0.001 | 40.052 | 5.299–302.762 | < 0.001 |
Abbreviations: HR hazard ratio, CI confidence interval
a In both univariable and multivariable Cox regression analyses, risk score and age were evaluated as continuous variables, and gender and TNM stage were evaluated as category variables
bP < 0.05 was considered statistically significant in all analyses